These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17209351)

  • 1. [Neurotoxicity of cyclosporine].
    Kozłowska I; Rózańiski J; Ciechanowski K
    Wiad Lek; 2006; 59(7-8):516-20. PubMed ID: 17209351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine-A induced neurotoxicity after renal transplantation.
    Derici U; Arinsoy T; Sindel S; Tali T; Leventoglu A; Sert S
    Acta Neurol Belg; 2001 Jun; 101(2):124-7. PubMed ID: 11486560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem].
    Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B
    Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
    Ahmadi F; Naseri R; Lessan-Pezeshki M
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical mechanisms of cyclosporine neurotoxicity.
    Serkova NJ; Christians U; Benet LZ
    Mol Interv; 2004 Apr; 4(2):97-107. PubMed ID: 15087483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine trough levels and its side effects in kidney transplant recipients.
    Hami M; Mojahedi MJ; Naghibi M; Shakeri MT; Sharifipour F
    Iran J Kidney Dis; 2010 Apr; 4(2):153-7. PubMed ID: 20404428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical neurologic illness in the immunocompromised patient.
    Cohen JA; Raps EC
    Neurol Clin; 1995 Aug; 13(3):659-77. PubMed ID: 7476823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine in Pediatric Nephrology.
    Arslansoyu Camlar S; Soylu A; Kavukçu S
    Iran J Kidney Dis; 2018 Nov; 12(6):319-330. PubMed ID: 30595561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine-induced white and grey matter central nervous system lesions in a pediatric renal transplant patient.
    Jeruss J; Braun SV; Reese JC; Guillot A
    Pediatr Transplant; 1998 Feb; 2(1):45-50. PubMed ID: 10084760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease after heart transplantation.
    Hamour IM; Omar F; Lyster HS; Palmer A; Banner NR
    Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential diagnosis between rejection and cyclosporine toxicity.
    Mihatsch MJ; Ryffel B; Gudat F
    Kidney Int Suppl; 1995 Dec; 52():S63-9. PubMed ID: 8587287
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
    Koh H; Yamane T; Nakane T; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Nakamae H; Koh KR; Mochizuki K; Hayashi N; Hino M
    Rinsho Ketsueki; 2006 Dec; 47(12):1539-43. PubMed ID: 17233473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation: a case report and review of the literature.
    Drachman BM; DeNofrio D; Acker MA; Galetta S; Loh E
    J Heart Lung Transplant; 1996 Nov; 15(11):1158-64. PubMed ID: 8956125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine-associated encephalopathy: a case report and literature review.
    Chang SH; Lim CS; Low TS; Chong HT; Tan SY
    Transplant Proc; 2001; 33(7-8):3700-1. PubMed ID: 11750577
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine induced neurotoxicity in a stem cell transplant recipient.
    Raza S; Ullah K; Ahmed P; Satti TM; Kamal MK; Chaudhry QU
    J Pak Med Assoc; 2007 Dec; 57(12):611-3. PubMed ID: 18173046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial hypertension in renal transplantation.
    Sandrini S; Gaggia P; Bracchi M; Gaggiotti M; Brunori G; Maiorca R
    Contrib Nephrol; 1996; 119():16-25. PubMed ID: 8783585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Usefulness of the EEG recording in the diagnosis of cyclosporin A-induced encephalopathy].
    Sueiras M; González N; Rovira R; Padró L
    Rev Neurol; 1998 May; 26(153):766-9. PubMed ID: 9634664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports.
    Dzudie A; Boissonnat P; Roussoulieres A; Cakmak ; Mosbah K; Bejui FT; Obadia JF; Sebbag L
    Transplant Proc; 2009 Mar; 41(2):716-20. PubMed ID: 19328965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.